Read + Share
Edwards K, Li X, Lingvay I. Clinical and Safety Outcomes with GLP-1 Receptor Agonists and SGLT2 Inhibitors in
Type 1 Diabetes: A Real-World Study. J Clin Endocrinol Metab 2022 Oct 21. pii: 6765301. doi: 10.1210.
PMID: 36268825
|
 |
|
Edwards K, Li X, Lingvay I. Clinical and Safety Outcomes with GLP-1 Receptor Agonists and SGLT2 Inhibitors in
Type 1 Diabetes: A Real-World Study. J Clin Endocrinol Metab 2022 Oct 21. pii: 6765301. doi: 10.1210.
PMID: 36268825
|
|
|
|